Scientists are making rapid progress toward a long-awaited goal that could help to reshape cancer care: mRNA cancer vaccines ...
BioNTech (NasdaqGS:BNTX) cofounders Ugur Sahin and Özlem Türeci are leaving their roles as CEO and Chief Medical Officer.
Misinformation about mRNA cancer vaccines threatens their transformative potential in treatment and prevention, highlighting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results